Current Neuro-Oncology
Volume
27 Number 29
20 October 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 29, 20 October
Valentini C, Perwein T, Bison B, Gielen GH, Knerlich-Lukoschus F,
Bock HC, Seidel C, Kortmann RD, Sturm D, Benesch M, Nussbaumer G,
Krischer JM, V Bueren A, Eyrich M, Friker LL, Hoffmann M, Gkika E,
Wittig-Sauerwein A, Hörner-Rieber J, Schwarz R, Jablonska K,
Hoffmann W, Vordermark D, Rieken S, Höng L, Rödel C,
Timmermann B, Fennell JT, Claviez A, Karremann M, Kramm CM, Krause
M.
Haematotoxicity of Craniospinal
Radiochemotherapy for Metastatic Paediatric High-Grade Glioma.
Clin
Oncol (R Coll Radiol). 2025 Oct 11;48:103956. doi:
10.1016/j.clon.2025.103956. PMID:
41207064. Observational
study˰ ˍ
Almeida ND, Schrand TV, Madhugiri V, Fang M, Cheruvu H, Shekher R,
Goulenko V, Snyder KV, Lipinski L, Fabiano AJ, Fenstermaker RA,
Prasad D.
Early Initiation of
Radiation Therapy Improves Survival in Elderly Patients With
Glioblastoma.
Neurosurgery.
2025 Oct 13. doi:
10.1227/neu.0000000000003768. PMID:
41081517. Observational study. ˍ
Saito R, Hanihara M, Okamoto T, Fujihara M, Muto Y, Kazama H,
Mochizuki K, Yoshioka H, Kinouchi H.
Antitumor
Effect of Selumetinib for Brainstem Glioma in an Adult With NF1: A
Case Report.
Neurosurg
Pract. 2025 Oct 13;6(4):e000175. doi:
10.1227/neuprac.0000000000000175. PMID:
41163739. Case report. ˍ
Anghileri E, Miele E, Patrizi S, Barresi S, Lazzarini E, Maddaloni
L, Patanè M, Pedace L, Paterra R, Silvani A, Locatelli F,
Indraccolo S, Pollo B.
Unique Genetic
and Epigenetic Alterations in Glioblastoma Long-Term Survivors:
Insights From Two Clinical Cases.
J
Cell Mol Med. 2025 Oct 14;29(20):e70771. doi:
10.1111/jcmm.70771. PMID:
41085137. Case report. ˍ
Koay JM, Dion C, Michaelides L, Chaichana K, Gruenbaum BF,
Middlebrooks EH, Quinones-Hinojosa A, Sabsevitz DS.
Cognitive
impact of repeated surgical resections for the management of
high-grade glioma.
J
Neurooncol. 2025 Oct 14;176(1):4. doi:
10.1007/s11060-025-05283-8. PMID:
41085575. Observational
study˰ ˍ
Harlay V, Bequet C, Appay R, Bertucci A, Petrirena G, Campello C,
Barrié M, Autran D, Graillon T, Dufour H, Figarella-Branger
D, Padovani L, Barlier A, Nanni I, Tabouret E, Chinot O.
Autonomy
duration in patients with biopsy-only unresectable IDH wild-type
glioblastomas.
J
Neurooncol. 2025 Oct 16;176(1):20. doi:
10.1007/s11060-025-05250-3. PMID:
41099970. Observational study˰
ˍ
Roux A, Tauziede-Espariat A, Simboli GA, Elia A, Moiraghi A,
Hudelist B, Defrance G, Gehanno A, Dezamis E, Blauwblomme T,
Dangouloff-Ros V, Boddaert N, Dufour C, Grill J, Muto J, Metais A,
Saffroy R, Varlet P, Chretien F, Oppenheim C, Zanello M, Pallud J.
High-grade glioma, IDH- and
H3-wildtype in young adults: a rare condition with a distinct
epigenetic landscape.
J
Neurooncol. 2025 Oct 16;176(1):22. doi:
10.1007/s11060-025-05246-z. PMID:
41099772. Observational
study. ˍ
Schiff D, Ye X, Li J, Ellingson BM, Wen PY, Walbert T, Campian J,
Burt Nabors L, Ozer BH, Desai A, Omuro A, Desideri S, Danda N,
Grossman S, Bindra RS.
Phase I/II and
Window-of-Opportunity Study of Pamiparib and Metronomic
Temozolomide for Recurrent IDH Mutant Gliomas.
Neuro
Oncol. 2025 Oct 16:noaf246. doi:
10.1093/neuonc/noaf246. PMID:
41099363. Interventional
study˰
ˍ
Spanggaard I, Matrana M, Lima CR, Mahipal A, Vieito M, Hervieu A,
Goyal L, Rodón J, Veronese ML, Oliveira N, Li X, Schaffer
M, Kesari S.
Pemigatinib for
Previously Treated Metastatic or Unresectable Central Nervous
System Tumors with FGFR Mutations or Rearrangements: FIGHT-207
Results.
Oncologist.
2025 Oct 16:oyaf272. doi:
10.1093/oncolo/oyaf272. PMID:
41100064. Interventional study.
ˍ
Tolboom N, Albert NL, Braat AJAT, Snijders TJ, Tabouret E,
Taillandier L, Brendel M, Cecchin D, Aguiar-Fernandez P, Fraioli
F, Guedj E, Traub-Weidinger T, Yakushev I, Van Weehaeghe D,
Preusser M, Verger A.
From
Compassionate Use Toward High-Level Evidence for
Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1
and MOMENTUM-1 Trials.
J
Nucl Med. 2025 Oct 16:jnumed.125.270820. doi:
10.2967/jnumed.125.270820. PMID:
41101976. Editorial. ˍ